vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and PJT Partners Inc. (PJT). Click either name above to swap in a different company.
PJT Partners Inc. is the larger business by last-quarter revenue ($531.4M vs $359.9M, roughly 1.5× AdvanSix Inc.). PJT Partners Inc. runs the higher net margin — 10.0% vs -0.8%, a 10.8% gap on every dollar of revenue. On growth, PJT Partners Inc. posted the faster year-over-year revenue change (12.9% vs 9.4%). PJT Partners Inc. produced more free cash flow last quarter ($138.6M vs $36.1M). Over the past eight quarters, PJT Partners Inc.'s revenue compounded faster (27.5% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
ASIX vs PJT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $531.4M |
| Net Profit | $-2.8M | $53.4M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 23.1% |
| Net Margin | -0.8% | 10.0% |
| Revenue YoY | 9.4% | 12.9% |
| Net Profit YoY | -892.9% | 4.0% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $531.4M | ||
| Q3 25 | $374.5M | $442.3M | ||
| Q2 25 | $410.0M | $401.1M | ||
| Q1 25 | $377.8M | $321.9M | ||
| Q4 24 | $329.1M | $470.5M | ||
| Q3 24 | $398.2M | $320.3M | ||
| Q2 24 | $453.5M | $358.1M | ||
| Q1 24 | $336.8M | $327.1M |
| Q4 25 | $-2.8M | $53.4M | ||
| Q3 25 | $-2.6M | $39.8M | ||
| Q2 25 | $31.4M | $32.9M | ||
| Q1 25 | $23.3M | $54.0M | ||
| Q4 24 | $352.0K | $51.3M | ||
| Q3 24 | $22.3M | $22.1M | ||
| Q2 24 | $38.9M | $28.3M | ||
| Q1 24 | $-17.4M | $32.6M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 23.1% | ||
| Q3 25 | -0.9% | 20.6% | ||
| Q2 25 | 7.7% | 19.1% | ||
| Q1 25 | 7.7% | 16.3% | ||
| Q4 24 | -3.9% | 21.9% | ||
| Q3 24 | 7.5% | 15.4% | ||
| Q2 24 | 11.5% | 18.0% | ||
| Q1 24 | -7.0% | 16.5% |
| Q4 25 | -0.8% | 10.0% | ||
| Q3 25 | -0.7% | 9.0% | ||
| Q2 25 | 7.7% | 8.2% | ||
| Q1 25 | 6.2% | 16.8% | ||
| Q4 24 | 0.1% | 10.9% | ||
| Q3 24 | 5.6% | 6.9% | ||
| Q2 24 | 8.6% | 7.9% | ||
| Q1 24 | -5.2% | 10.0% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — | ||
| Q1 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $538.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $308.2M |
| Total Assets | $1.7B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $538.9M | ||
| Q3 25 | $23.7M | $400.5M | ||
| Q2 25 | $18.4M | $214.6M | ||
| Q1 25 | $8.3M | $194.3M | ||
| Q4 24 | $19.6M | $483.9M | ||
| Q3 24 | $17.3M | $148.8M | ||
| Q2 24 | $12.1M | $164.2M | ||
| Q1 24 | $20.6M | $215.5M |
| Q4 25 | $815.2M | $308.2M | ||
| Q3 25 | $818.2M | $228.6M | ||
| Q2 25 | $823.7M | $167.4M | ||
| Q1 25 | $794.4M | $148.8M | ||
| Q4 24 | $774.6M | $187.0M | ||
| Q3 24 | $766.4M | $159.1M | ||
| Q2 24 | $746.6M | $133.8M | ||
| Q1 24 | $713.2M | $174.6M |
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.5B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $155.7M |
| Free Cash FlowOCF − Capex | $36.1M | $138.6M |
| FCF MarginFCF / Revenue | 10.0% | 26.1% |
| Capex IntensityCapex / Revenue | 7.7% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 2.92× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $480.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $155.7M | ||
| Q3 25 | $26.6M | $256.1M | ||
| Q2 25 | $21.1M | $190.4M | ||
| Q1 25 | $11.4M | $-75.9M | ||
| Q4 24 | $64.2M | $195.7M | ||
| Q3 24 | $57.3M | $180.5M | ||
| Q2 24 | $50.2M | $193.6M | ||
| Q1 24 | $-36.2M | $-38.8M |
| Q4 25 | $36.1M | $138.6M | ||
| Q3 25 | $66.0K | $240.9M | ||
| Q2 25 | $-7.2M | $178.9M | ||
| Q1 25 | $-22.6M | $-77.9M | ||
| Q4 24 | $29.8M | $195.3M | ||
| Q3 24 | $26.8M | $178.5M | ||
| Q2 24 | $16.7M | $193.0M | ||
| Q1 24 | $-71.6M | $-39.2M |
| Q4 25 | 10.0% | 26.1% | ||
| Q3 25 | 0.0% | 54.5% | ||
| Q2 25 | -1.7% | 44.6% | ||
| Q1 25 | -6.0% | -24.2% | ||
| Q4 24 | 9.1% | 41.5% | ||
| Q3 24 | 6.7% | 55.7% | ||
| Q2 24 | 3.7% | 53.9% | ||
| Q1 24 | -21.3% | -12.0% |
| Q4 25 | 7.7% | 3.2% | ||
| Q3 25 | 7.1% | 3.4% | ||
| Q2 25 | 6.9% | 2.9% | ||
| Q1 25 | 9.0% | 0.6% | ||
| Q4 24 | 10.4% | 0.1% | ||
| Q3 24 | 7.7% | 0.6% | ||
| Q2 24 | 7.4% | 0.1% | ||
| Q1 24 | 10.5% | 0.1% |
| Q4 25 | — | 2.92× | ||
| Q3 25 | — | 6.43× | ||
| Q2 25 | 0.67× | 5.79× | ||
| Q1 25 | 0.49× | -1.41× | ||
| Q4 24 | 182.29× | 3.81× | ||
| Q3 24 | 2.57× | 8.15× | ||
| Q2 24 | 1.29× | 6.84× | ||
| Q1 24 | — | -1.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PJT
Segment breakdown not available.
